Filter
3100
Filtered Results: 3100
Text search:
adverse
health
outcomes
Featured
Recommendations
330
New Publications
798
Language
Document type
No document type
1725
Studies & Reports
513
Guidelines
501
Manuals
151
Strategic & Response Plan
99
Fact sheets
44
Training Material
42
Situation Updates
14
Resource Platforms
6
Infographics
2
Brochures
1
App
1
Online Courses
1
Countries / Regions
India
147
Global
130
Kenya
71
Western and Central Europe
71
South Africa
69
Ethiopia
66
Nigeria
53
Nepal
48
Uganda
41
Africa
40
Sierra Leone
39
Latin America and the Carribbean
36
Zambia
36
Tanzania
35
Malawi
34
Bangladesh
34
Ghana
33
Liberia
32
Philippines
31
Myanmar / Burma
30
Rwanda
25
Eastern Europe
24
South–East Asia Region
23
Cambodia
21
Namibia
21
Ukraine
18
Brazil
18
Zimbabwe
15
East and Southern Africa
15
Asia
14
Syria
13
Indonesia
13
Lesotho
12
Guinea
12
USA
12
Colombia
10
Mozambique
10
Eastern Europe and Central Asia
10
Botswana
10
West and Central Africa
9
Middle East and North Africa
9
Senegal
8
Thailand
7
Burkina Faso
7
Germany
7
Western Pacific Region
7
South Sudan
7
Eswatini/ Swaziland
7
Pakistan
7
Chile
6
Haiti
6
Congo, Democratic Republic of
6
Moldova
6
Russia
6
Sudan
6
Afghanistan
5
Venezuela
5
Jordan
5
Lebanon
5
Cameroon
4
Laos
4
Paraguay
4
United Kingdom
4
Argentina
4
Ecuador
4
Timor Leste/ East Timor
3
Benin
3
Egypt
3
Palestine
3
Somalia
3
Tajikistan
2
China
2
Singapore
2
Niger
2
Bolivia
2
Vietnam
2
Papua New Guinea
2
Yemen
2
Romania
2
Georgia
2
Central African Republic
2
Angola
2
Bhutan
2
Madagascar
2
North Macedonia
1
El Salvador
1
Australia
1
Gambia
1
Kazakhstan
1
Iran
1
Albania
1
Canada
1
Kyrgyzstan
1
Burundi
1
Peru
1
Bulgaria
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
North America
1
Japan
1
Mauritius
1
Sri Lanka
1
Poland
1
Honduras
1
Mali
1
Libya
1
Iraq
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
991
Clinical Guidelines
365
Public Health
195
Women & Child Health
176
Key Resources
133
Capacity Building
46
Pharmacy & Technologies
29
Toolboxes
Mental Health
339
TB
235
COVID-19
225
HIV
221
Planetary Health
161
NCDs
89
Caregiver
87
Pharmacy
87
AMR
80
NTDs
72
Rapid Response
70
Ebola
58
Global Health Education
58
Disability
54
Conflict
50
Refugee
49
Zika
33
Natural Hazards
25
Health Financing Toolbox
19
Cholera
16
Polio
16
Specific Hazards
15
Social Ethics
6
Typhoon
1
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
The "Questions and Answers on Prevention and control of Alcohol related harm" has been developed by WHO country office in Viet Nam with technical contribution from national and international experts in the field. This publication provides scientific evidences on harms of alcohol use to the health of...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
Skin-related neglected tropical diseases, or “skin NTDs”, are historically neglected because active case detection, individual case management, significant resources and intensive effort are required to control, eliminate and eradicate them. Integrated control and management of skin NTDs offers ...
Vector-borne diseases are responsible for 17% of the global burden of communicable diseases and more than 500 000 deaths annually. The ambitious global targets for the control of vector-borne diseases come in the context of the (re-)emergence of diseases, increasing resistances to insecticides and u...
Safe drinking-water management must consider drinking-water quality, acceptability and quantity in the context of public health protection. In this manual, the term “safety” encompasses these three elements. Although the principles in this manual can be broadly applied to all types of drinking-w...
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination...
Children continue to be exposed to powerful food marketing, which predominantly promotes foods high in saturated fatty acids, trans-fatty acids, free sugars and/or sodium and uses a wide variety of marketing strategies that are likely to appeal to children. Food marketing has a harmful impact on chi...
This guideline provides updated, evidence-informed guidance on the percentage of total fat in the diet to reduce the risk of unhealthy weight gain.
This guideline is intended for a wide audience involved in the development, design and implementation of policies and programmes in nutrition and pub...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande...
This technical report has been developed within the framework of the WHO Global Initiative for
Childhood Cancer. Its goal is to improve the situation of children and adolescents with cancer worldwide,
giving them the best chances of survival, living a full life and, above all, enjoying quality of ...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
One of the main aims of the WHO Global Initiative for Childhood Cancer and the CureAll Americas framework is to strengthen centers of excellence and promote the training of the health workforce, especially pediatric oncology nurses, specialized in nursing care for children and adolescents with cance...
The Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020 by the World Health Organization (WHO) outlines a comprehensive strategy to address the global rise in noncommunicable diseases (NCDs), including cardiovascular diseases, cancer, chronic respiratory diseases,...
Non-Communicable Diseases (NCDs), including mental disorders, currently pose one of the biggest threats to health and development globally, particularly in low and middle income countries2. It is predicted that unless proven interventions are rapidly implemented in countries, in the short to medium ...
On August 13, 2024, the Africa CDC declared the mpox outbreak a Public Health Emergency of Continental Security (PHECS). The following day, the WHO declared it a Public Health Emergency of International Concern (PHEIC). A coordinated, continent-wide response is essential, co-led by the African Union...
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on the mechanism to develop a practically applicable h...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to...
